ABSI Live signaler | Maksimer profitt med Getagraph.com

KJøP 136703 min ago

@ $4.70

Utstedt: 14 feb 2024 @ 20:13

Avkastning: -1.81%

Forrige signal: feb 13 - 17:04

Forrige signal: Selg

Avkastning: 12.71 %

Live Chart Being Loaded With Signals

Commentary (17 mai 2024 @ 22:00):

Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States...

Stats
Dagens volum	545 040
Gjennomsnittsvolum	1.33M
Markedsverdi	521.88M
EPS	$0 ( 2024-05-14 )
Neste inntjeningsdato	( $-0.190 ) 2024-05-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.85
ATR14	$0.00700 (0.15%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-19	Mcclain Sean	Buy	1 500 000	Common Stock
2024-03-01	Redmile Group, Llc	Buy	222 222	Common Stock
2023-12-31	Phoenix Venture Partners Ii Lp	Buy	0
2024-02-01	Bedrick Todd	Buy	20 570	Common Stock
2024-02-01	Bedrick Todd	Buy	86 790	Stock Option (right to buy)

INSIDER POWER
99.64
Last 93 transactions
Buy: 45 572 968 \| Sell: 7 130 968

Volum Korrelasjon

Lang: 0.22 (neutral)

Kort: 0.98 (very strong)

Signal:(61.882) Expect same movement, but be aware

Absci Corporation Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Absci Corporation Korrelasjon - Valuta/Råvare

0.42
( neutral )

0.33
( neutral )

0.00
( neutral )

-0.31
( neutral )

-0.35
( neutral )

Absci Corporation Økonomi

Annual	2023
Omsetning:	$5.72M
Bruttogevinst:	$-8.28M (-144.82 %)
EPS:	$-1.200

FY	2023
Omsetning:	$5.72M
Bruttogevinst:	$-8.28M (-144.82 %)
EPS:	$-1.200

FY	2022
Omsetning:	$5.75M
Bruttogevinst:	$-7.29M (-126.85 %)
EPS:	$-1.150

FY	2021
Omsetning:	$4.78M
Bruttogevinst:	$-1.87M (-39.15 %)
EPS:	$-1.117

Financial Reports:

No articles found.

Absci Corporation Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Absci Corporation

Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.

Sanntidsoppdatering for Absci Corporation [ABSI]

Upcoming Earnings Alert

Absci Corporation Options Data

Calls

Puts